Background illustration for clinical trials search

Paid Clinical Trials Cleveland

Discover 1,397 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

for
Dravet Syndrome
Location: Cleveland OH, Ann Arbor MI, Columbus OH, Rochester NY,
Sponsor: Stoke Therapeutics, Inc

Sex: All

Age: 2 - 17

Code: NCT06872125

Phase3, Recruiting
Active & Responsive

Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis

for
Dermatomyositis
Location: Cleveland OH
Sponsor: The Cleveland Clinic

Sex: All

Age: 18 - 70+

Code: NCT06857240

Phase2, Recruiting
Active & Responsive

A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)

for
Lower Extremity Acute Limb Ischemia, LE ALI
Location: Cleveland OH, Cincinnati OH, Indianapolis IN,
Sponsor: Penumbra Inc.

Sex: All

Age: 18+

Code: NCT06747117

Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

for
Huntington Disease
Location: Cleveland OH, Detroit MI, Pittsburgh PA, Buffalo NY,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 21 - 70

Code: NCT07326709

Phase3, Recruiting
Active & Responsive

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Location: Cleveland OH, Detroit MI, Columbus OH, Falls Church VA,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT01915511

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

for
Single Ventricle Heart Disease
Location: Cleveland OH, Pittsburgh PA, Ann Arbor MI, Columbus OH,
Sponsor: Mezzion Pharma Co. Ltd

Sex: All

Age: 12 - 18

Code: NCT05918211

Phase3, Recruiting
Active & Responsive

Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients

for
Mobility Limitation, Frailty, Hospital Acquired Condition,
Location: Cleveland OH, Garfield Heights OH, Mayfield Heights OH,
Sponsor: The Cleveland Clinic

Sex: All

Age: 65+

Code: NCT05725928

Recruiting
Active & Responsive

Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial

for
Parkinson Disease
Location: Cleveland OH
Sponsor: Jay Alberts

Sex: All

Age: 18+

Code: NCT06442033

Recruiting
Active & Responsive

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

for
Glioblastoma
Location: Cleveland OH, Pittsburgh PA, Toronto,
Sponsor: Global Coalition for Adaptive Research

Sex: All

Age: 18+

Code: NCT03970447

Phase2, Phase3, Recruiting
Active & Responsive

Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL

for
CLL/SLL
Location: Cleveland OH, Canton OH, Charlotte NC, Boston MA,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18 - 70+

Code: NCT04215809

Phase1, Recruiting
Active & Responsive

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

for
Non-small Cell Lung Cancer, Histiocytic Neoplasm, Histiocytosis,
Location: Cleveland OH, Grand Rapids MI, Fairfax VA, New York NY,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT05786924

Phase1, Phase2, Recruiting
Active & Responsive

CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting

for
Cardiac Valve Disease
Location: Cleveland OH, Toronto, Indianapolis IN, Philadelphia PA,
Sponsor: Corcym S.r.l

Sex: All

Age: 0+

Code: NCT05002543

Recruiting
Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Cleveland OH, Canton OH, Pittsburgh PA, Ann Arbor MI,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase2, Phase3, Recruiting
Active & Responsive

Changes in Microbial Status From Dentate, Edentulous and After Dental Implant Placement

for
Edentulous Mouth, Periodontal Diseases, Periodontitis, Adult,
Location: Cleveland OH
Sponsor: Case Western Reserve University

Sex: All

Age: 21+

Code: NCT06149585

Recruiting
Active & Responsive

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

for
Age-Related Macular Degeneration, Geographic Atrophy
Location: Cleveland OH, Birmingham MI, Eatontown NJ, Asheville NC,
Sponsor: VisionCare, Inc.

Sex: All

Age: 65+

Code: NCT05438732

Recruiting
Active & Responsive

Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms

for
Barrett Esophagus, Gastroesophageal Reflux,
Location: Cleveland OH, Baltimore MD, Chapel Hill NC, Aurora CO
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 50+

Code: NCT06687603

Recruiting
Active & Responsive

Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

for
Solid Tumor
Location: Cleveland OH, Canton OH
Sponsor: Lamassu Bio Inc

Sex: All

Age: 18+

Code: NCT06578624

Phase1, Phase2, Recruiting
Active & Responsive

Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

for
Cyst of Pancreas, Pancreatectomy, Pancreas Neoplasm
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05720338

Phase3, Recruiting
Active & Responsive

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

for
Urothelial Carcinoma
Location: Cleveland OH, Pittsburgh PA, Toronto, Indianapolis IN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05562830

Phase1, Phase2, Recruiting
Active & Responsive

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

for
Bladder Cancer
Location: Cleveland OH, Chicago IL, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07232602

Phase1, Phase2, Recruiting